China Life invests 4 billion RMB to participate in the establishment of a partnership enterprise, investing in innovative companies in the AI, integrated circuits, and biomedicine industries

China Life (02628.HK) announced that it plans to enter into a partnership agreement with "Pudong Venture Capital," "Guotou Xiandao," and "China Life Infrastructure" (all parties acting as limited partners), along with "Chuangzhi HeRui" (acting as the general partner) and "Lingzhi Ying Shanghai" (acting as the special limited partner) to establish a partnership enterprise. The total capital contribution from all partners of the partnership enterprise is RMB 5.052 billion (the same below), of which the company's capital contribution is RMB 4 billion. China Life Capital will serve as the manager of the partnership enterprise.

The operating period of the partnership enterprise is from the date of the first issuance of the business license until ten years after the first delivery date. The five-year period starting from the first delivery date is the investment period of the partnership enterprise, and the five-year period following the end of the investment period is the exit period of the partnership enterprise. Based on the operational needs of the partnership enterprise, the operating period may be extended twice by unanimous agreement of all partners, with each extension lasting one year.

The investment fields of the partnership enterprise mainly focus on technology innovation enterprises in the three leading industries of artificial intelligence, integrated circuits, and biomedicine